Table 4 Exploratory outcomes of change from baseline in functional outcomes

From: Gene therapy with bidridistrogene xeboparvovec for limb-girdle muscular dystrophy type 2E/R4: phase 1/2 trial results

 

Cohort 1 (dose, 1.85 × 1013 vg kg−1)a (n = 3)

Cohort 2 (dose, 7.41 × 1013 vg kg−1)b (n = 3)

Natural history cohort (n = 5)

Month 6 (n = 3)

Year 1 (n = 3)

Year 2 (n = 3)

Month 6 (n = 3)

Year 1 (n = 2)

Year 2 (n = 2)

Month 6 (n = 5)

Year 1 (n = 5)

Year 2 (n = 5)

NSAD score

         

Mean (s.d.)

3.0 (1.7)

5.7 (1.5)

5.7 (1.5)

3.7 (3.5)

4.0 (1.4)

0.5 (0.7)

–2.2 (3.7)

–2.0 (2.1)

–5.3 (3.1)

Median (range)

4.0 (1.0, 4.0)

6.0 (4.0, 7.0)

6.0 (4.0, 7.0)

4.0 (0, 7.0)

4.0 (3.0, 5.0)

0.5 (0, 1.0)

−1.0 (−7.0, 2.0)

−2.0 (−4.0, 1.0)

−6.0 (−8.0, −2.0)

Time to rise, s

      

Mean (s.d.)

−0.2 (0.8)

−0.8 (0.4)

−0.6 (0.2)

−1.3 (0.9)

−1.1 (1.1)

−0.7 (0.4)

   

Median (range)

−0.6 (−0.7, 0.8)

−0.6 (−1.2, −0.5)

−0.6 (−0.7, −0.4)

−0.8 (−2.3, −0.7)

−1.1 (−1.8, −0.3)

−0.7 (−1.0, −0.4)

   

Four-stair climb, s

      

Mean (s.d.)

−0.5 (0.4)

−0.5 (0.3)

−0.3 (0.4)

−0.4 (0.3)

−0.4 (0)

−0.3 (0.3)

   

Median (range)

−0.4 (−0.9, −0.1)

−0.5 (−0.8, −0.2)

−0.5 (−0.6, 0.2)

−0.4 (−0.7, −0.1)

−0.4 (−0.4, −0.4)

−0.3 (−0.5, −0.1)

   

100-m walk, s

         

Mean (s.d.)

−3.8 (2.9)

−5.3 (3.2)

−2.8 (6.4)

−6.3 (6.7)

−7.9 (5.4)

−2.9 (9.7)

−0.8 (5.6)

1.6 (6.8)

5.2 (10.2)

Median (range)

−4.6 (−6.2, 0.6)

−3.6 (−8.9, −3.3)

−4.4 (−8.2, 4.2)

−2.8 (−14.0, −2.1)

−7.9 (−11.7, −4.1)

−2.9 (−9.7, 4.0)

1.2 (−7.5, 5.5)

3.3 (−8.1, 7.7)

9.0 (−6.4, 13.0)

10-m walk, s

         

Mean (s.d.)

−0.6 (0.3)

−0.6 (0.2)

−0.2 (0.5)

−0.6 (0.6)

−0.6 (0.2)

−0.3 (0.9)

−0.7 (0.6)

−0.2 (0.7)

−0.1 (0.3)

Median (range)

−0.6 (−0.9, −0.3)

−0.5 (−0.9, −0.5)

−0.3 (−0.6, 0.3)

−0.3 (−1.3, −0.2)

−0.6 (−0.7, −0.4)

−0.3 (−0.9, 0.4)

−0.7 (−1.5, 0)

−0.1 (−1.0, 0.6)

−0.1 (−0.3, 0.1)

  1. A positive (+) change in NSAD and a negative (−) change in timed tests indicate improvement in function.
  2. a1.85 × 1013 vg kg−1 (linear standard qPCR).
  3. b7.41 × 1013 vg kg−1 (linear standard qPCR).